Live Earnings Conference Call: MariMed's Q3 2026 earnings call is happening now. OTCMKTS:MRMD MariMed Q3 2026 Earnings Results & Report $0.07 +0.00 (+2.76%) As of 11/11/2026 03:59 PM Eastern MariMed met analyst earnings expectations and beat on revenue in its Q3 2026 results, released November 11, 2026. The company reported EPS of -$0.01 versus the -$0.01 consensus estimate, while revenue of $44.23 million topped the $41.20 million estimate by $3.03 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 11, 2026TimeAfter Market ClosesConference Call DateNovember 12, 2026Conference Call8:00 AM ET Live Call not available Live EventEarnings Conference CallMariMed Q3 202600:00 / 00:00Live Transcript Follow Audio MariMed EPS ResultsActual EPS-$0.01Consensus EPS -$0.01Beat/MissMet ExpectationsOne Year Ago EPSN/AEPS Beat Rate0 of last 8 quartersMariMed Revenue ResultsActual Revenue$44.23 millionExpected Revenue$41.20 millionBeat/MissBeat by +$3.03 millionYoY Revenue GrowthN/AConference Call ResourcesSlide DeckPress Release (8-K)Earnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Earnings DocumentsPress Release(8-K) MariMed Q3 2026 Earnings FAQ Did MariMed beat earnings estimates for Q3 2026? MariMed (OTCMKTS:MRMD) reported earnings of -$0.01 per share for Q3 2026, matching the consensus estimate of -$0.01. The report was announced on Wednesday, November 11, 2026. What was MariMed's revenue for Q3 2026? MariMed reported revenue of $44.23 million for Q3 2026, against a consensus estimate of $41.20 million. MariMed Earnings HeadlinesMariMed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 20263 hours ago | marketscreener.comMMariMed Reports Third Quarter 2026 EarningsNovember 11 at 5:00 PM | globenewswire.comTrump, Schiff and Dalio all point to the same warning signIn 1929, the Dow fell 89 percent and took 25 years to recover. A 60-year-old who held on wasn't made whole until age 85. Today, the national debt sits at 38.86 trillion dollars, a level the market has never faced before. Economists including Peter Schiff and Ray Dalio point to a classic bubble forming.November 12 at 1:00 AM | USA Capital Gold (Ad)Thrive Dispensaries Awards $20,000 to Support Veterans Facing Housing Challenges through Annual Help on the Homefront CampaignNovember 11 at 7:00 AM | globenewswire.comMariMed Q3 earnings previewNovember 10 at 8:18 PM | msn.comEarnings To Watch: MariMed Inc (MRMD) Q3 2026 -- GF Value Sees 86% UpsideNovember 10 at 8:54 AM | finance.yahoo.comSee More MariMed Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like MariMed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MariMed and other key companies, straight to your email. Email Address About MariMedMariMed (OTCMKTS:MRMD), Inc. is a U.S.-based cannabis company that develops, operates and manages licensed cannabis cultivation, processing and dispensary facilities. The company serves both medical and adult-use markets, where permitted by state law, and focuses on producing and distributing cannabis flower, concentrates, edibles, tinctures and other cannabis-infused products. MariMed markets products under brands that have included Betty’s Eddies, Nature’s Heritage, InHouse and Kalm Fusion. Its products are sold through the company’s retail operations and third-party dispensaries in its operating markets. MariMed has also provided management and operational services to cannabis businesses, including support in cultivation, manufacturing, retail operations, compliance and brand development. The company has operated in several state-regulated cannabis markets, including Massachusetts, Maryland, Delaware and Ohio. MariMed was established in 2011 and has expanded through the development and acquisition of cannabis businesses and licenses. Jon Levine serves as the company’s chief executive officer and chairman.View MariMed ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Keeping AI Cool: AAON Rides the AI Heatwave to Record GrowthCan Constellation Energy's Contracts Power a Stock Rebound?IonQ Raised the Bar, But 3 Quantum Rivals Face Tough QuestionsAmazon's Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI DemandAST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn't Going AwayPowering Up the Moon: Redwire’s $40 Million NASA Award Upcoming Earnings Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
